Kristin Brooks, Contract Pharma06.02.15
The CRO industry plays an ever increasing role in the development of new medicines globally and legislative and regulatory policy can have a tremendous impact on clinical research. ACRO, the Association of Clinical Research Organizations, and its members advocate on a global basis for safe, ethical, high-quality medical research and engages with national and global agencies on important issues affecting drug development. The legislative, business and regulatory environment for clinical research play an imperative role in promoting the development of new medicines.
According to ACRO, about half of clinical trials take place in the U.S.—more than any other nation in the world. ACRO’s legislative agenda in the U.S. is focused on promoting policies that foster innovation in the drug development process and ensure that the U.S. remains a competitive venue for clinical trials—in addition to advocating for a better-funded, scientifically-advanced FDA. Its current legislative priorities include: lobbying to advance tax policies that recognize the critical role CROs play in research & development and ensure that the U.S. remain globally compe
According to ACRO, about half of clinical trials take place in the U.S.—more than any other nation in the world. ACRO’s legislative agenda in the U.S. is focused on promoting policies that foster innovation in the drug development process and ensure that the U.S. remains a competitive venue for clinical trials—in addition to advocating for a better-funded, scientifically-advanced FDA. Its current legislative priorities include: lobbying to advance tax policies that recognize the critical role CROs play in research & development and ensure that the U.S. remain globally compe
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
